Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice

Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice

Bibliographic Details
Main Authors:	Wang, Li-Li, Liu, Wen-Jia, Liu, Hai-Yun, Xu, Xun
Format:	Online
Language:	English
Published:	Medknow Publications & Media Pvt Ltd 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831540/

Similar Items

Plasma metabolomic study in Chinese patients with wet age-related macular degeneration
by: Dan Luo, et al.
Published: (2017-09-01)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
by: Garba, Adinoyi O., et al.
Published: (2010)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
by: Adinoyi O. Garba, et al.
Published: (2010-01-01)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
by: Adinoyi O. Garba, et al.
Published: (2010-12-01)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
by: Chaikin, Laurie, et al.
Published: (2015)

Future Therapies of Wet Age-Related Macular Degeneration
by: Ishikawa, Makoto, et al.
Published: (2015)

Imaging of Wet Age-Related Macular Degeneration
by: Kenan, Damer
Published: (2016)

Research progress on risk factors of wet age-related macular degeneration
by: Meng Wang, et al.
Published: (2018-09-01)

Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research
by: Wolf, Armin, et al.
Published: (2014)

Effects of Intravitreal Ranibizumab Injection on Chinese Patients with Wet Age-Related Macular Degeneration: 5-Year Follow-Up Results
by: Lu, Yingyi, et al.
Published: (2016)

Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
by: Chen, Youxin, et al.
Published: (2012)

Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
by: Senra, Hugo, et al.
Published: (2016)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
by: Suetsugu, Tetsuyuki, et al.
Published: (2016)

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
by: Neffendorf, James E, et al.
Published: (2015)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
by: García-Layana, Alfredo, et al.
Published: (2015)

Wide-Field Fluorescein Angiography in Wet Age-Related Macular Degeneration
by: Madhusudhan, Savitha, et al.
Published: (2014)

Evaluation of circulating miRNAs in wet age-related macular degeneration
by: Ertekin, Sevda, et al.
Published: (2014)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
by: Keles, Sadullah, et al.
Published: (2014)

Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
by: Stewart, Michael W
Published: (2012)

Early initial clinical experience with intravitreal aflibercept for wet age-related macular degeneration
by: Ferrone, Philip J, et al.
Published: (2014)

StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial
by: Neffendorf, James E., et al.
Published: (2016)

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
by: Kaya, Abdullah
Published: (2016)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
by: Razi, Faraz, et al.
Published: (2016)

Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration
by: Pierro, Luisa, et al.
Published: (2012)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
by: Dervenis, Nikolaos, et al.
Published: (2016)

Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
by: Mukherjee, Chandoshi, et al.
Published: (2015)

Correction: Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
Published: (2015)

Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA
by: Ferreira, Alberto, et al.
Published: (2015)

Apolipoprotein E gene and age-related macular degeneration in a Chinese population
by: Sun, Erdan, et al.
Published: (2011)

Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis
by: Ba, Jun, et al.
Published: (2015)

24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting
by: Athanasios Vardarinos, et al.
Published: (2017-04-01)

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
by: Constable, Ian J., et al.
Published: (2016)

Age-related macular degeneration – clinical review and genetics update
by: Ratnapriya, R, et al.
Published: (2013)

Age-Related Macular Degeneration: Clinical Findings following Treatment with Antiangiogenic Drugs
by: Casaroli-Marano, Ricardo, et al.
Published: (2014)

Update on Clinical Trials in Dry Age-related Macular Degeneration
by: Taskintuna, Ibrahim, et al.
Published: (2016)

Critical Appraisal of Clinical Practice Guidelines for Age-Related Macular Degeneration
by: Wu, Annie M., et al.
Published: (2015)

Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration
by: Alvarez Palomo, Ana Belen, et al.
Published: (2015)

Age-related macular degeneration
by: Querques, Giuseppe, et al.
Published: (2011)

Macrophages and Macular Degeneration
by: Jager, Martine J.
Published: (2014)

Advances in the management of macular degeneration
by: Singer, Michael
Published: (2014)